Shi Qingxin, Wang Xuanyuan, Liu Junyi, Xiang Xingliang, Su Mingwu, Huang Rongzeng, Song Chengwu
College of Pharmacy, Hubei University of Chinese Medicine, Wuhan, Hubei, China.
Iran J Pharm Res. 2019 Spring;18(2):867-876. doi: 10.22037/ijpr.2019.1100666.
The decoction of is used as a traditional medicine for treatment of asthma in China with a long clinical history. The aim of the study was to investigate the anti-asthma activities of an active components group obtained from the decoction of in histamine and ovalubumin induced asthma guinea pigs. The experimental asthma model was established with spray of histamine and ovalbumin (OVA) followed by intragastric administration of extract and fractions. The incubation period of asthma, serum IFN-γ, IL-4, and LTB4 levels were tested and determined. In addition, liquid chromatography-quadrupole time of flight mass spectrometry (LC-QTOF-MS/MS) was used to identify the bioactive components in active fraction. The significant increase of asthma incubation period, serum IFN-γ level were observed in the asthma guinea pigs treated with the active components group. The serum IL-4 and LTB4 levels were obviously decreased compared to that of model controls. In addition, twenty oligopeptides were first identified or characterized in the active fraction from the decoction of . The results indicated that can inhibit infiltration and diffusion of inflammatory cells in asthma model guinea pigs, and regulate IFN-γ, IL-4, and LTB4 secretions. It is reasonable to assume that the anti-asthma activities of mainly resulted from these oligopeptides. Also, synergistic effects among their compounds may exist in the anti-asthma activity of .
在中国,[药物名称]汤剂作为治疗哮喘的传统药物已有很长的临床历史。本研究的目的是探讨从[药物名称]汤剂中获得的活性成分组对组胺和卵清蛋白诱导的哮喘豚鼠的抗哮喘活性。通过喷雾组胺和卵清蛋白(OVA)建立实验性哮喘模型,随后灌胃给予[药物名称]提取物和馏分。检测并测定哮喘的潜伏期、血清IFN-γ、IL-4和LTB4水平。此外,采用液相色谱-四极杆飞行时间质谱(LC-QTOF-MS/MS)鉴定活性馏分中的生物活性成分。在用活性成分组治疗的哮喘豚鼠中观察到哮喘潜伏期显著延长、血清IFN-γ水平显著升高。与模型对照组相比,血清IL-4和LTB4水平明显降低。此外,首次从[药物名称]汤剂的活性馏分中鉴定或表征了20种寡肽。结果表明,[药物名称]可以抑制哮喘模型豚鼠中炎症细胞的浸润和扩散,并调节IFN-γ、IL-4和LTB4的分泌。可以合理推测,[药物名称]的抗哮喘活性主要源于这些寡肽。此外,其化合物之间在[药物名称]的抗哮喘活性中可能存在协同作用。